We report the case of a newborn with alveolar capillary dysplasia with misalignment of pulmonary veins (ACD/MPV), a rare condition of unknown etiology presenting in the neonatal period with significant persistent pulmonary hypertension. The diagnosis was made by lung biopsy and confirmed at autopsy. Specific genetic analysis demonstrated defects in the FOXF1 gene. The diagnosis of ACD/MPV requires a high level of suspicion and is made by lung biopsy or necropsy examination by a pediatric pathologist with experience in this condition. The availability of genetic testing has led to increasing diagnosis of patients with this lethal disorder and can influence their management, specifically by indicating the need for lung biopsy in a critically ill newborn. Journal of Perinatology (2013) 33, 401-403; doi:10.1038/jp.2012.63
Introduction
Alveolar capillary dysplasia with misalignment of pulmonary veins (ACD/MPV) is a rare, universally fatal developmental disorder of the lung affecting both the parenchyma and vasculature. The persistent pulmonary hypertension in this disorder leads to severe, intractable respiratory distress and cyanosis, followed by progressive respiratory failure. The diagnosis of ACD/MPV requires a high level of suspicion and is made through lung biopsy or necropsy by a pediatric pathologist with related experience. Mutations of the FOXF1 gene are identified in 40% of ACD/MPV cases, but DNA testing for this disease is currently available in very few laboratories.
Case
A female newborn was transferred to our center on her eighth day of life for hypoxemic respiratory failure secondary to persistent pulmonary hypertension. The pregnancy was uneventful and the neonate's Apgar scores were 10, 10 and 10 at 1, 5 and 10 min, respectively. At 8 h of life, the patient had developed respiratory distress with trembling, which was attributed to polycythemia. Partial exchange transfusion was performed with a decrease in hematocrit, but she presented progressive hypoxemia with increasing oxygen requirements. The chest radiograph showed bilateral alveolar infiltrates and echocardiography highlighted pulmonary hypertension (systolic pulmonary arterial pressure estimated through tricuspid regurgitation was 70 mm Hg) and a patent foramen ovale (right-left shunt). She was connected to mechanical ventilation (FiO 2 1) and needed continuous infusion of inotropic support, sedoanalgesia and curarization. Nitric oxide (NO), hydrocortisone, sildenafil and infusion of prostacyclin were also started. Broad-spectrum antibiotic therapy was given and clarithromycin was added because of persistent alveolar infiltrates on chest radiographs (it was not possible to rule out interstitial pneumonitis). High-frequency ventilation was attempted to treat progressive hypoxemia, but it was not well tolerated. Because of the possibility that extracorporeal membrane oxygenation (ECMO) might be needed, the decision was made to transfer her to our center. We tried to improve oxygenation with high-frequency ventilation, NO (40 p.p.m.) and endotracheal surfactant as rescue therapy, but she continued to be poorly oxygenated. Veno-venous ECMO was started and 10 h later, she had stabilized, but hemodynamic deterioration occurred and ECMO was converted to veno-arterial type. The patient remained stable on ECMO for 7 days and after this time (15 days of life) she was placed on conventional mechanical ventilation. Despite continuous treatment for pulmonary hypertension, she worsened 48 h later, and corticosteroids, bosentan, hydroxychloroquine and a new course of macrolides were added to her treatment. Ultrasound study of the abdomen and brain yielded normal findings.
At 19 days of life, lung biopsy was performed and the pathologic study was consistent with ACD/MPV ( Figure 1 ). Despite intensive treatment, baseline hemoglobin saturation decreased progressively, and she had more frequent hypertensive crises. At 38 days of life, she died due to a pulmonary hypertension crisis that was resistant to treatment.
At clinical autopsy, macroscopic examination showed non-nodular pulmonary lobulation of both lungs. A decline in the number of capillaries in the alveolar septa and detachment of the epithelial lining was observed. Secondary proximal and distal obstructive pulmonary vascular disease was evident (plexiform arteriopathy and abnormal focal muscularization of intra-acinar arteries), as was diffuse venous-venule ectasia in several areas of the parenchyma, septa, bronchovascular axis and subpleural space.
A DNA sample from the patient and blood samples from both parents were sent to the Department of Molecular and Human Genetics at Baylor College of Medicine in Houston. The patient's DNA testing confirmed a pathogenic FOXF1 gene mutation (frameshift mutation in the first exon), which confirmed our diagnosis. The mutation was not present in DNA of either parent and was considered a de novo event. The family was informed that there is a very low risk of recurrence in future pregnancies.
Discussion
The term ACD refers to failure in the formation and growth of the alveolar capillaries, a condition characterized by an absence or decrease of capillaries adjacent to the alveolar epithelium, alveolar septal thickening, and hypertrophy of the middle muscular layer of the small pulmonary arteries, with increased muscularization of intra-acinar arterioles. MVP is caused by anomalous location (malposition) of the smaller pulmonary veins, which are found adjacent to the bronchioles and pulmonary arterioles in the bronchovascular axis rather than their usual location in the interlobular septum. Anomalously situated pulmonary veins run alongside the pulmonary arterioles and share the same adventitial sheath. Some researchers believe that although ACD probably reflects a vasculogenesis imbalance, MPV suggests an imbalance of angiogenesis.
1,2 Most cases are sporadic, although familial cases also occur (10%), suggesting an autosomal recessive inheritance. The disorder is associated with persistent pulmonary hypertension of the neonate and shows varying degrees of lability and severity. 3 Affected infants present with respiratory distress in the early postnatal period resulting from pulmonary hypertension, and the disease is uniformly fatal within the newborn period. 4 Some patients have additional congenital malformations, such as heart defects (in particular, hypoplastic left heart syndrome), gastrointestinal atresia (including esophageal atresia), urinary tract malformations and disruption of the normal right-left asymmetry of intrathoracic or intra-abdominal organs. These data suggest that the molecular pathophysiological factors underlying ACD may also affect development of the genitourinary, cardiovascular and gastrointestinal systems due to defects of components of the molecular pathways (such as transcription factor genes), which, when disrupted, adversely affect development of these systems. 5 The FOXF1 gene (cr16q24.1) (OMIM 601089) has a crucial role in the development of the lung and its vasculature. Mutations (deletions or point mutations) of this gene have been identified in patients with ACD/MPV. 1, 6 FOXF1 belongs to the forkhead family of transcription factors and contributes to regulation of pulmonary genes and embryonic development. In a group of patients with ACD/MPV, Sen et al. 6 identified six overlapping microdeletions encompassing the FOX transcription factor gene cluster on chromosome 16q24.1-24.2, all but one of which included the FOXF1 gene. This first report highlighted the importance of the FOX cluster, and especially of FOXF1, in the pathogenesis of ACD/MVP. FOXF1 sequencing identified point mutations in patients without deletions in the FOX transcription factor gene cluster. Cases involving rearrangements or point mutations have additional congenital malformations.
6 FOXF1 point mutations have been associated with bowel malrotation, whereas FOXF1 microdeletions have been related with hypoplastic left heart syndrome and gastrointestinal atresia, attributed to haploinsufficiency for the neighboring FOXC2 (OMIM 602402) and FOXL1 (OMIM 603252) genes (both genes also belong to the forkhead family of transcription factors). These associations could be explained by deletions harboring FOXF1 and the neighboring FOXC2 and FOXL1 genes at 16q24.1. It seems that ACD/MVP results from haploinsufficiency of FOXF1 and that the differences in the associated malformations relate to haploinsufficiency of Figure 1 Lung biopsy with details of bronchovascular axis. From the two bronchioles (large empty arrows), marked arteriolar muscular hyperplasia that nearly occludes the lumen (thin arrow) and venous vascular structures interposed between the bronchiole and arteriole (large black arrow) can be observed.
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Y Castilla-Fernandez et al FOXC2 and FOXL1. FOXC2 may have a role in the development of mesenchymal tissues, and point mutations are likely responsible for lymphedema-distichiasis syndrome, in which a small percentage of patients have congenital heart defects. The specific function of FOXL1 has not yet been determined; however, it is suggested that patients with intestinal atresia, isolated diastasis recti or umbilical hernia should be screened for FOXL1 gene mutations and deletions. 6 Over 90% of neonates with ACD/MPV are born at term and in most cases (60%), the symptoms start within 48 h of life. 7 Nonetheless, there are reports of cases in which the condition develops later, 8 even into adulthood. ACD/MPV predominantly occurs in males, with a 3:2 male:female ratio. 9 Half the patients have associated gastrointestinal (40%), genitourinary (32%) or cardiovascular anomalies (16%).
1 Cardiac malformations, esophageal and anal atresia, renal and vertebral/axial malformations, and single umbilical artery appear to be common to both the VACTERL association and 16q24.1 microdeletion. However, although lung malformations have been reported occasionally in cases of VACTERL association, ACD/MPV has not been described in this context. Therefore, 16q24.1 microdeletions should be considered in cases of apparent VACTERL association with severe neonatal respiratory distress or lethality. 6, 10 Other rare associations with ACD/ MPV include anterior segment ocular dysgenesis and phocomelia hemivertebrae. Chest radiography is often nonspecific, although pneumothorax is found in some cases.
11
The definite diagnosis is based on lung biopsy examination or autopsy by a pediatric pathologist with prior experience in the diagnosis of ACD/MPV. 1, 7 Overall, 90% of cases are diagnosed at autopsy, and 10% by premortem lung samples. It is important to point out that our patient was diagnosed while alive, and that biopsy was performed because pathologic study provides valuable prognostic information. 7 Considering that up to 40% of ACD/MPV cases have FOXF1 gene mutations or deletions, it is important to know that a blood test is currently available (in a small number of laboratories worldwide) to establish the diagnosis. Negative testing does not exclude the diagnosis, however, and histological examination remains the gold standard. FOXF1 mutation analysis is the first step towards providing prenatal diagnoses to families at high risk, 7, 9, 12 and to diagnose patients in whom biopsy or autopsy was not performed.
Currently, no specific treatment is available for ACD/MPV, and despite the various strategies used for the management of pulmonary hypertension, the mortality rate is nearly 100%. 1 Treatment with NO and ECMO provide time for a potential lung transplantation; hence, even with the current mortality rate, it is important to diagnose this condition at an early stage to avoid costly procedures. In our case, we considered the possibility of including the child on the waiting list for lung transplant, but because of her poor clinical status and the expectation of a long wait, the family decided against it after considering the risks and benefits.
